Richard Braatz to lead a new center for continuous mRNA manufacturing

A pilot-scale system, enabled by an $82 million award from the FDA, aims to accelerate the development and production of mRNA technologies. The engineering challenges will be tackled by researchers at MIT as well as collaborators at Penn State University and Rensselaer Polytechnic Institute